Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
RETINOL PALMITATE VITAMIN D SYNTHETIC CALCIFEROL THIAMINE MONONITRATE PYRIDOXINE HYDROCHLORIDE CYANOCOBALAMIN ASCORBIC ACID TOCOPHEROL NICOTINAMIDE CALCIUM PANTOTHENATE CALCIUM PHOSPHATE PHOSPHORUS FERROUS FUMARATE MAGNESIUM OXIDE RIBOFLAVIN LYSINE CHOLINE COPPER IODINE INOSITOL POTASSIUM MILK POWDER SOYA PROTEIN ZINC OXIDE MANGANESE DIOXIDE
Pfizer Consumer Healthcare Ltd
Granules for Oral Suspension
1998-04-01
PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Gevral Instant Protein Orange Flavour 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For excipients see section 6.1. 3 PHARMACEUTICAL FORM Granules for oral suspension. A fine cream coloured powder with an orange flavour. Active constituents Vitamin A Palmitate 1250 IU Vitamin D 3 125 IU VitaminB 1 (as thiamine mononitrate) 1.1 mg Vitamin B 2 (Riboflavin) 1.1 mg Vitamin B 6 (Pyridoxine HCl) 0.1 mg Vitamin B 12 (as cobalamin concentrate-the extract from streptomyces fermentation) 0.5 micrograms Vitamin C (Ascorbic Acid) 12.5 mg Vitamin E (_dl_-Alpha tocopherol acetate) 2.25 IU Pantothenic acid (as Calcium pantothenate) 1.8 mg Niacin 5.25 mg Calcium (as dibasic calcium phosphate and from soya protein isolate and non fat milk powder) 150 mg Phosphorus (as dibasic calcium phosphate and from soya protein isolate and non fat milk powder) 160 mg Elemental Iron (as ferrous fumarate and from soya protein isolate and non-fat milk powder) 3.0 mg Lysine (from soya protein isolate and non-fat milk powder) 450 mg Choline (from choline, non-fat milk powder and soya protein isolate) 13 mg Inositol (from inositol, non-fat milk powder and soya protein isolate) 37.5 mg Copper (as copper oxide) 0.3 mg Iodine (as potassium iodide) 37.5 micrograms Potassium (from potassium sulphate and soya protein isolate) Not less than 45 mg Manganese (as manganese dioxide and from non-fat milk powder and soya protein isolate) 0.35 mg Zinc (as zinc oxide) 0.4 mg Magnesium (as magnesium oxide and from non-fat milk powder) 5.5 mg IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 10/01/2006_ _CRN 2018448_ _page number: 1_ 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS In the management of appropriate vitamin and mineral deficiencies. 4.2 P Read the complete document